UP!

AMED $95.49

AMED target price
95.49
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2022 2022-10-31 Future report Set alerts
Q2 2022 2022-07-27 1.47 1.47
Q1 2022 2022-04-27 1.23 1.23
Q4 2021 2022-02-23 1.18 1.18
Q3 2021 2021-11-02 1.53 1.53
Q2 2021 2021-08-04 1.69 1.69
Q1 2021 2021-04-28 1.54 1.54
Q4 2020 2021-02-24 1.49 1.49
Q3 2020 2020-10-28 0.00 0.00
Q2 2020 2020-07-28 1.34 1.04

Ratings

2016-06-16 Initiated Coverage Stephens Equal Weight $55.00
2016-05-25 Reiterated Rating Jefferies Group Buy $59.00
2016-05-16 Reiterated Rating Robert W. Baird Hold
2016-05-06 Boost Price Target RBC Capital Sector Perform $41.00 to $48.00
2016-05-06 Boost Price Target Royal Bank Of Canada Sector Perform $41.00 to $48.00
2016-05-04 Reiterated Rating Oppenheimer Buy $56.00
2016-05-04 Reiterated Rating Oppenheimer Holdings Inc. Buy $56.00
2016-04-11 Reiterated Rating Mizuho Buy $49.00 to $57.00
2016-03-17 Reiterated Rating Oppenheimer Outperform $45.00
2016-03-11 Reiterated Rating Mizuho Buy $49.00
2016-03-10 Reiterated Rating Jefferies Group Buy $48.00
2016-03-10 Reiterated Rating Oppenheimer Outperform $40.00 to $45.00
2016-02-08 Upgrade Oppenheimer Market Perform to Outperform $40.00
2016-01-19 Upgrade Mizuho Neutral to Buy $45.00 to $49.00
2016-01-13 Lower Price Target Robert W. Baird Neutral $43.00 to $39.00
2016-01-11 Upgrade Raymond James Underperform to Market Perform
2016-01-11 Upgrade Raymond James Financial Inc. Underperform to Market Perform
2015-11-27 Boost Price Target RBC Capital Sector Perform $25.00 to $41.00
2015-11-26 Upgrade Robert W. Baird Underperform to Neutral $9.00 to $10.00
2015-11-26 Lower Price Target Jefferies Group Hold $15.00 to $12.00
2015-11-11 Downgrade Mizuho Buy to Neutral $45.00
2015-11-06 Reiterated Rating Piper Jaffray Neutral $42.00 to $45.00
2015-11-06 Reiterated Rating Piper Jaffray Cos. Neutral $42.00 to $45.00
2015-10-06 Reiterated Rating Oppenheimer Market Perform
2015-09-01 Initiated Coverage Wells Fargo & Co. Outperform
2015-09-01 Initiated Coverage Wells Fargo Outperform
2015-07-16 Reiterated Rating Piper Jaffray Hold $30.00 to $41.00
2015-06-30 Initiated Coverage Mizuho Buy $45.00
2015-06-19 Upgrade Jefferies Group Hold to Buy $30.00 to $48.00
2015-06-09 Upgrade Deutsche Bank Hold to Buy $28.00 to $41.00
2015-06-09 Reiterated Rating Jefferies Group Hold
2015-06-09 Upgrade Deutsche Bank AG Hold to Buy $28.00 to $41.00
2015-05-27 Upgrade SunTrust Neutral to Buy $31.00 to $36.00
2015-05-27 Upgrade SunTrust Banks Inc. Neutral to Buy $31.00 to $36.00
2015-05-24 Reiterated Rating Deutsche Bank Hold $28.00
2015-05-07 Reiterated Rating RBC Capital Sector Perform $23.00 to $25.00
2015-04-30 Boost Price Target Deutsche Bank Hold $27.00 to $28.00
2015-03-05 Reiterated Rating Oppenheimer Hold
2015-03-05 Boost Price Target Jefferies Group Hold $25.00 to $30.00
2015-03-05 Reiterated Rating Piper Jaffray Neutral $24.00 to $28.00
2014-12-01 Upgrade RBC Capital Underperform to Sector Perform $10.00 to $23.00
2014-10-30 Reiterated Rating Jefferies Group Hold $16.50 to $25.00
2014-10-30 Reiterated Rating Credit Suisse Underperform $17.00 to $23.00
2014-10-30 Reiterated Rating Credit Suisse Group AG Underperform $17.00 to $23.00
2014-10-29 Upgrade Robert W. Baird Underperform to Neutral $15.00 to $25.00
2014-07-31 Reiterated Rating SunTrust Neutral $18.00 to $23.00
2014-07-31 Reiterated Rating Credit Suisse Underperform $9.00 to $17.00
2014-07-31 Reiterated Rating Deutsche Bank Hold $14.00 to $22.00
2014-07-31 Boost Price Target Piper Jaffray Neutral $12.00 to $18.00
2014-07-31 Boost Price Target Jefferies Group Hold $12.00 to $16.50
2014-07-18 Boost Price Target RBC Capital Underperform $7.00 to $10.00
2014-06-30 Upgrade Deutsche Bank Sell to Hold $8.00 to $14.00
2014-06-27 Upgrade CRT Capital Sell to Fair Value
2014-06-02 Downgrade Avondale Partners Outperform to Market Perform
2014-05-12 Lower Price Target Piper Jaffray $13.00 to $12.00
2014-03-13 Lower Price Target Credit Suisse $10.00 to $9.00
2014-03-11 Downgrade Oppenheimer Outperform to Market Perform $16.00
2013-11-25 Upgrade Avondale Partners Market Perform to Outperform
2013-11-13 Downgrade Deutsche Bank Hold to Sell $11.00 to $8.00
2013-11-12 Downgrade CRT Capital Fair Value to Sell
2013-10-28 Reiterated Rating Credit Suisse Underperform $10.00 to $16.91
2013-10-21 Downgrade RBC Capital Sector Perform to Underperform $10.00 to $9.00
2013-08-09 Upgrade CRT Capital Sell to Fair Value
2013-06-28 Reiterated CRT Capital Sell $3
2013-03-13 Reiterated Argus Hold $12 to $11
2012-05-15 Upgrade Robert W. Baird Underperform to Neutral $9 to $10
2012-03-08 Reiterated RBC Capital Mkts Sector Perform $11 to $13
2012-01-10 Downgrade Robert W. Baird Neutral to Underperform $10 to $8
2011-10-27 Downgrade BB&T Capital Mkts Hold to Underweight
2011-02-23 Reiterated RBC Capital Mkts Sector Perform $29 to $38
2011-02-23 Reiterated Oppenheimer Outperform $38 to $44
2011-02-23 Reiterated FBR Capital Mkt Perform $31 to $35
2011-01-27 Upgrade Jefferies Hold to Buy $31 to $45
2011-01-18 Reiterated FBR Capital Mkt Perform $27 to $31
2010-12-21 Upgrade Deutsche Bank Hold to Buy $31 to $39
2010-10-27 Reiterated FBR Capital Mkt Perform $29 to $27
2016-06-16 Initiated Coverage Stephens Equal Weight $55.00
2016-05-25 Reiterated Rating Jefferies Group Buy $59.00
2016-05-16 Reiterated Rating Robert W. Baird Hold
2016-05-06 Boost Price Target RBC Capital Sector Perform $41.00 to $48.00
2016-05-06 Boost Price Target Royal Bank Of Canada Sector Perform $41.00 to $48.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
NORTH TIDE CAPITAL, LLC 9.97%  (3313300) AFAM / AMED / ELOS / HWAY / SEM / VVUS /
BORNE WILLIAM F Chief Executive Officer 1.33%  (440427) AMED /
LABORDE RONALD A 0.59%  (196738) AMED /
Kusserow Paul B. K. CEO and President 0.27%  (90008) AMED / CNXR / HUM /
PITTS DAVID R 0.26%  (88021) AMED /
NETTERVILLE JACK L 0.24%  (79893) AMED /
RICCHIUTI PETER 0.23%  (76600) AMED /
WASHBURN DONALD A 0.22%  (71791) AMED / GBX / KTEC / LHO /
BARFIELD T A JR Chief Development Officer 0.14%  (45353) AMED /
KKR Asset Management LLC 0.13%  (42053) AMED / KKR /
Snow Michael D Chief Operating Officer 0.12%  (40892) AMED / TMH /
JETER JEFFREY D Chief Compliance Officer 0.11%  (36770) AMED /
REDMAN DALE E Chief Financial Officer 0.09%  (30843) AMED /
Bucey David R General Counsel and Secretary 0.07%  (24484) AMED /
Hall Linda J. 0.07%  (24402) AMED / IRET /
North Michael Paul Chief Information Officer 0.07%  (22731) AMED /
McCoy Daniel P Chief Operating Officer 0.07%  (21988) AMED /
Ginn Scott G Principal Accounting Officer 0.07%  (21694) AMED /
Gerard Christopher Chief Operating Officer 0.06%  (21537) AMED /
Kemmerly David L See Remarks 0.06%  (20879) AMED /
Fleming Michael O. Chief Medical Officer 0.06%  (19952) AMED /
Seim Stephen Chief Strategy Officer 0.06%  (19355) AMED /
Pernosky Lawrence R Chief Human Resources Officer 0.06%  (19069) AMED /
WILLIS GARY D Chief Financial Officer 0.06%  (18878) AMED /
PERKINS BRUCE D 0.05%  (17725) AMED / HUM /
Zilkha Nathaniel M 0.05%  (16490) AMED /
Pearce David B. Chief Compliance Officer 0.05%  (16190) AMED /
Howard Martin B Chief Information Officer 0.05%  (15485) AMED /
Sender Susan Chief Clinical Officer 0.05%  (15026) AMED /
Klapstein Julie D 0.02%  (5333) AMED / QSII / SR /
LECHLEITER RICHARD A 0.02%  (5333) AMED / KND / SYBT /
Rideout Jeffrey A 0.02%  (5333) AMED /